Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-23

Clinical Trial Update: Adherence of Stalevo, Entacapone and Levodopa

View source ↗

Summary

A completed clinical trial evaluating adherence to Stalevo (carbidopa-levodopa-entacapone) and its components in individuals with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entacapone (Entacapone)
  • Stalevo (levodopa;carbidopa;entacapone)
  • levodopa (levodopa)

Snippet

Sponsor: South Glasgow University Hospitals NHS Trust | Conditions: Parkinson's Disease | Status: COMPLETED